| Ytd | 24.42% | |
| 1y | 12.37% |
| Open | 313.39 | Prev Close | 314.20 | Low | 311.62 | High | 318.18 | Mkt Cap | 25.32B |
| Vol | 607.87K | Avg Vol | 742.58K | EPS | 12.09 | P/E | 25.82 | Forward P/E | 15.74 |
| Beta | 0.85 | Short Ratio | 3.50 | Inst. Own | 101.79% | Dividend | 2.88 | Div Yield | 0.92 |
| Ex Div Date | 08-28 | Earning | 10-28 | 50-d Avg | 319.90 | 200-d Avg | 281.49 | 1yr Est | 344.19 |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
BURLINGTON, N.C., Sept. 30, 2026 /PRNewswire/ -- Labcorp Holdings Inc.
LH expands specialty testing and consumer services through acquisitions, partnerships and AI, while
Labcorp Holdings Inc. (NYSE: LH - Get Free Report) shares gapped down prior to trading on Tuesday. T
HCA Healthcare (NYSE: HCA - Get Free Report) and Labcorp (NYSE: LH - Get Free Report) are both large
Labcorp shares dropped sharply after CMS released preliminary 2027 lab-payment rates, aligning Medic
Labcorp Holdings Inc. is upgraded to Buy, supported by resilient demand for diagnostics and robust Q
On September 21, 2026, the Centers for Medicare & Medicaid Services ("CMS") released pre
Medicare and Medicaid have been overpaying Labcorp for years, says the government. Starting next yea
U.S. stock futures were mixed. Ericsson fell 4.3% after a Morgan Stanley downgrade; Quest Diagnostic
Truist Securities analyst David Macdonald maintains Labcorp Holdings (NYSE:LH) with a Buy and rai
Labcorp Holdings Inc. (LH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Trans
Read this week's top deal updates, including Bending Spoons' Miro deal, Chime's Stride B
UBS analyst Kevin Caliendo maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price t
Barclays analyst Luke Sergott maintains Labcorp Holdings (NYSE:LH) with a Equal-Weight and raises
Labcorp Holdings Inc. (LH) Analyst/Investor Day Transcript
Labcorp Holdings (NYSE:LH) on Thursday presented a comprehensive growth strategy and long-term finan
Labcorp shares its strategic priorities and reaffirms 2026 guidance at its Investor Day, forecasting
Reaffirms full-year 2026 guidanceProvides long-term outlook through 2029, with compound annual reven
Labcorp Holdings (NYSE:LH) affirms FY2026 Adj EPS guidance from $18.10-$18.55 to $18.10-$18.55 vs $1
Reaffirms full-year 2026 guidance Provides long-term outlook through 2029, with compound annual reve
Concurrent Investment Advisors LLC grew its holdings in Labcorp Holdings Inc. (NYSE: LH) by 64.4% in
GREENWICH, Conn. and MÖNCHENGLADBACH, Germany--(BUSINESS WIRE)--Great Point Partners (“GPP”), a Gree
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept.
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today annou
Acquisition establishes Labcorp as the only central laboratory provider with a wholly owned laborato
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
Enhanced digital experience designed to improve visibility, simplify workflows and support faster de
BURLINGTON, N.C., Aug. 28, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative an
Elecsys® pTau-217 is the first and only FDA-cleared single-biomarker blood test to both rule in and
Collaboration will support leadership development, practice improvement and innovation across the na
The assay helps identify patients who may be eligible for treatment with AstraZeneca's TRUQAP® (
JP Morgan analyst Lisa Gill maintains Labcorp Holdings (NYSE:LH) with a Overweight and raises the
Morgan Stanley analyst Ricky Goldwasser maintains Labcorp Holdings (NYSE:LH) with a Overweight an
Truist Securities analyst David Macdonald maintains Labcorp Holdings (NYSE:LH) with a Buy and rai
Barclays analyst Jack Meehan maintains Labcorp Holdings (NYSE:LH) with a Equal-Weight and raises
Labcorp Holdings (NYSE:LH) raises FY2026 Adj EPS guidance from $17.70-$18.35 to $18.10-$18.55 vs $18
Laboratory Corp (NYSE:LH) reported quarterly earnings of $4.99 per share which beat the analyst cons
B of A Securities analyst Michael Ryskin maintains Labcorp Holdings (NYSE:LH) with a Buy and rais
Baird analyst Eric Coldwell maintains Labcorp Holdings (NYSE:LH) with a Outperform and raises the
Illumina, Inc. (NASDAQ:ILMN) and Labcorp (NYSE:LH), a global leader of innovative and comprehensive
Tech stocks hit new highs as the Nasdaq 100 rallies 0.7% midday. Investors eye a Fed rate cut, Trump